Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
185.00
-2.40 (-1.28%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Axsome Therapeutics Analyst Ratings
Total Analysts
17
Consensus Rating
Strong Buy
Price Target
$211.12
Upside
+14.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $251 → $259 | Strong Buy | Maintains | $251 → $259 | +40.00% | Apr 10, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $220 → $245 | Strong Buy | Maintains | $220 → $245 | +32.43% | Mar 25, 2026 |
| UBS | UBS | Strong Buy Maintains $248 → $251 | Strong Buy | Maintains | $248 → $251 | +35.68% | Feb 24, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $205 → $220 | Strong Buy | Maintains | $205 → $220 | +18.92% | Feb 24, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $219 → $222 | Buy | Maintains | $219 → $222 | +20.00% | Feb 24, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $193 → $202 | Buy | Maintains | $193 → $202 | +9.19% | Feb 24, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $230 | Buy | Initiates | $230 | +24.32% | Feb 24, 2026 |
| Needham | Needham | Strong Buy Reiterates $225 | Strong Buy | Reiterates | $225 | +21.62% | Feb 23, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $200 → $245 | Strong Buy | Maintains | $200 → $245 | +32.43% | Feb 3, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $150 → $205 | Buy | Maintains | $150 → $205 | +10.81% | Jan 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $212 → $219 | Buy | Maintains | $212 → $219 | +18.38% | Jan 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $200 → $260 | Strong Buy | Maintains | $200 → $260 | +40.54% | Jan 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $148 → $223 | Buy | Maintains | $148 → $223 | +20.54% | Jan 16, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $157 → $193 | Buy | Maintains | $157 → $193 | +4.32% | Jan 13, 2026 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $196 → $204 | Buy → Hold | Downgrades | $196 → $204 | +10.27% | Jan 8, 2026 |
| UBS | UBS | Strong Buy Maintains $163 → $248 | Strong Buy | Maintains | $163 → $248 | +34.05% | Jan 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.